Department of Health

Requirements for the treatment of skin cancer using Rhenium-188 unsealed brachytherapy compound

Management Licence condition M1768 requires management licence holders to comply with the requirements specified in the document titled “Requirements for the treatment of skin cancer using Rhenium-188 unsealed brachytherapy compound”. A copy of the document can be downloaded using the link below.

Should you have any questions regarding these requirements please email: Radiation.Safety@health.vic.gov.au.

Download

Reviewed 28 January 2024

Health.vic

Contact us

Radiation Safety

Was this page helpful?